| Year |
Citation |
Score |
| 2019 |
Kozela E, Krawczyk M, Kos T, Juknat A, Vogel Z, Popik P. Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats. Molecular Neurobiology. PMID 31823199 DOI: 10.1007/S12035-019-01831-2 |
0.593 |
|
| 2007 |
Kozela E, Popik P. A complete analysis of NMDA receptor subunits in periaqueductal grey and ventromedial medulla of morphine tolerant mice. Drug and Alcohol Dependence. 86: 290-3. PMID 16930867 DOI: 10.1016/J.Drugalcdep.2006.06.018 |
0.721 |
|
| 2005 |
Kozela E, Wrobel M, Kos T, Wojcikowski J, Daniel WA, Wozniak KM, Slusher BS, Popik P. 2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice. Psychopharmacology. 183: 275-84. PMID 16220328 DOI: 10.1007/S00213-005-0182-5 |
0.728 |
|
| 2005 |
Danysz W, Kozela E, Parsons CG, Sladek M, Bauer T, Popik P. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance. Neuropharmacology. 48: 360-71. PMID 15721168 DOI: 10.1016/J.Neuropharm.2004.11.005 |
0.767 |
|
| 2003 |
Popik P, Kozela E, Krawczyk M. Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram. British Journal of Pharmacology. 139: 1196-202. PMID 12871839 DOI: 10.1038/Sj.Bjp.0705359 |
0.625 |
|
| 2003 |
Popik P, Kozela E, Wróbel M, Wozniak KM, Slusher BS. Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 457-67. PMID 12629525 DOI: 10.1038/Sj.Npp.1300048 |
0.75 |
|
| 2003 |
Kozela E, Pilc A, Popik P. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology. 165: 245-51. PMID 12442203 DOI: 10.1007/S00213-002-1287-8 |
0.786 |
|
| 2002 |
Kozela E, Popik P. The effects of NMDA receptor antagonists on acute morphine antinociception in mice. Amino Acids. 23: 163-8. PMID 12373532 DOI: 10.1007/S00726-001-0123-5 |
0.745 |
|
| 2001 |
Kozela E, Danysz W, Popik P. Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. European Journal of Pharmacology. 423: 17-26. PMID 11438302 DOI: 10.1016/S0014-2999(01)01084-6 |
0.762 |
|
| 2001 |
Kozela E, Popik P, Danysz W. Dextromethorphan, memantine and MRZ 2/579, low affinity NMDA receptor antagonists, potentiate morphine antinociception recorded from the tail but not from the paw Pharmacological Reports. 53: 179-180. |
0.704 |
|
| 2000 |
Popik P, Kozela E, Pilc A. Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice. British Journal of Pharmacology. 130: 1425-31. PMID 10903986 DOI: 10.1038/Sj.Bjp.0703438 |
0.779 |
|
| 2000 |
Popik P, Kozela E, Danysz W. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 361: 425-32. PMID 10763858 DOI: 10.1007/S002109900205 |
0.783 |
|
| 1999 |
Popik P, Kozela E. Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test. Polish Journal of Pharmacology. 51: 223-31. PMID 10600036 |
0.767 |
|
| Show low-probability matches. |